YARAL Pharma Inc. is the US subsidiary of IBSA, a global pharmaceutical company headquartered in Switzerland. By focusing on people and innovating the ways they’re cared for, YARAL Pharma is proud to offer the same values and expertise of its parent company to the US market.
Dedicated to ensuring access to affordable authorized generics (AGs) and complex generic medicines that enhance healthcare outcomes, YARAL Pharma offers its customers high-quality products across a range of therapeutic areas, continuity of supply, and a commitment to exceptional customer service.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 8 Campus Dr,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.yaralpharma.com/
- HQ
- Parsippany, New Jersey
Yaral Pharma Questions
Yaral Pharma's website is https://www.yaralpharma.com/
Yaral Pharma's LinkedIn profile is https://www.linkedin.com/company/yaral-pharma
Yaral Pharma has
10 employees.
View email and phone details for 10
employees at Yaral Pharma.
Yaral Pharma's industry is
Pharmaceutical Manufacturing
Yaral Pharma's top competitors are
Ibsa Turkey,
Ibsa Usa,
Fierce Pharma,
Alvogen,
Sintetica,
Solaris Pharma Corporation,
Bryn Pharma,
Ibsa Group,
Higen Company,
Ibsa Italy.
Yaral Pharma's categories are Pharmaceutical Manufacturing
Yaral Pharma's founding year is 2021
